• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Connective tissue diseases: Is SLE many single-organ diseases or an overlapping spectrum?

作者信息

Merrill Joan T

机构信息

Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, MS 22, Oklahoma City, OK 73104, USA.

出版信息

Nat Rev Rheumatol. 2015 Jul;11(7):385-6. doi: 10.1038/nrrheum.2015.61. Epub 2015 May 5.

DOI:10.1038/nrrheum.2015.61
PMID:25939416
Abstract
摘要

相似文献

1
Connective tissue diseases: Is SLE many single-organ diseases or an overlapping spectrum?
Nat Rev Rheumatol. 2015 Jul;11(7):385-6. doi: 10.1038/nrrheum.2015.61. Epub 2015 May 5.
2
Systemic lupus erythematosus: a review of the disease and treatment options.系统性红斑狼疮：疾病及治疗选择综述
Consult Pharm. 2013 Feb;28(2):110-21. doi: 10.4140/TCP.n.2013.110.
3
[Systemic lupus erythematosus - news 2017].[系统性红斑狼疮——2017年新闻]
Wiad Lek. 2017;70(6 pt 2):1201-1204.
4
Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus: A Systematic Review of Clinical Practice Guidelines.系统性红斑狼疮的诊断、监测与治疗：临床实践指南的系统评价
Arthritis Care Res (Hoboken). 2015 Oct;67(10):1440-52. doi: 10.1002/acr.22591.
5
[Systemic lupus erythematosus--myths and dogma].[系统性红斑狼疮——误区与教条]
Ther Umsch. 2005 May;62(5):292-6. doi: 10.1024/0040-5930.62.5.292.
6
[Early diagnosis in patients with systemic lupus erythematosus (SLE)].[系统性红斑狼疮（SLE）患者的早期诊断]
Z Rheumatol. 2005 Nov;64(8):547-52. doi: 10.1007/s00393-005-0795-4.
7
[New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement].[系统性红斑狼疮分类与治疗的新视角：肾脏受累的核心作用]
G Ital Nefrol. 2013 Jul-Aug;30(4).
8
Clinical outcome and predictors of disease evolution in patients with incomplete lupus erythematosus.不完全性红斑狼疮患者的临床结局及疾病进展的预测因素
Lupus. 2000;9(2):110-5. doi: 10.1191/096120300678828073.
9
[Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].[成人及青少年系统性红斑狼疮感染的预防：基于文献和专家意见的临床实践指南]
Rev Med Interne. 2016 May;37(5):307-20. doi: 10.1016/j.revmed.2016.01.005. Epub 2016 Feb 16.
10
Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE).系统性红斑狼疮（SLE）的疾病特异性质量指标、指南及结局指标
Clin Exp Rheumatol. 2007 Nov-Dec;25(6 Suppl 47):107-13.

引用本文的文献

1
Philosophical and distinct SLE epitomes: dogmas in conflict with evidences and an intellectual dissonance between established pathophysiological models.哲学性且独特的系统性红斑狼疮缩影：与证据相冲突的教条以及既定病理生理模型之间的认知失调。
Front Immunol. 2025 Jul 24;16:1580664. doi: 10.3389/fimmu.2025.1580664. eCollection 2025.
2
The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.ALPHA 项目：建立共识和优先级，以解决狼疮诊断、护理、治疗和研究方面的主要挑战的全球社区建议。
Lupus Sci Med. 2021 Feb;8(1). doi: 10.1136/lupus-2020-000433.
3

本文引用的文献

1
Treatment Algorithms in Systemic Lupus Erythematosus.系统性红斑狼疮的治疗算法
Arthritis Care Res (Hoboken). 2015 Sep;67(9):1237-1245. doi: 10.1002/acr.22589.
2
Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply.对《辅助性T细胞17细胞因子与I型干扰素：系统性红斑狼疮中的共犯？》的回应——作者回复
Arthritis Res Ther. 2014;16(3):410. doi: 10.1186/ar4578.
3
Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
Global consensus building and prioritisation of fundamental lupus challenges: the ALPHA project.
全球狼疮基本挑战的共识构建与优先排序：ALPHA项目
Lupus Sci Med. 2019 Jul 19;6(1):e000342. doi: 10.1136/lupus-2019-000342. eCollection 2019.
4
Lupus community panel proposals for optimising clinical trials: 2018.狼疮患者群体关于优化临床试验的建议：2018年
Lupus Sci Med. 2018 Mar 23;5(1):e000258. doi: 10.1136/lupus-2018-000258. eCollection 2018.
5
Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.系统性红斑狼疮：定义、语境、冲突、谜团。
Front Immunol. 2018 Mar 1;9:387. doi: 10.3389/fimmu.2018.00387. eCollection 2018.
干扰素-α诱导健康及系统性红斑狼疮单核细胞中B淋巴细胞刺激因子的表达与动员
Rheumatology (Oxford). 2014 Dec;53(12):2249-58. doi: 10.1093/rheumatology/keu249. Epub 2014 Jun 18.
4
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.前瞻性观察性单中心队列研究评估利妥昔单抗联合霉酚酸酯治疗狼疮性肾炎而不使用口服皮质类固醇的疗效。
Ann Rheum Dis. 2013 Aug;72(8):1280-6. doi: 10.1136/annrheumdis-2012-202844. Epub 2013 Jun 5.
5
Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.贝利尤单抗，一种 B 淋巴细胞刺激因子特异性抑制剂，对系统性红斑狼疮患者多个器官疾病活动的影响：两项 III 期临床试验的联合结果。
Ann Rheum Dis. 2012 Nov;71(11):1833-8. doi: 10.1136/annrheumdis-2011-200831. Epub 2012 May 1.
6
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.利妥昔单抗治疗活动性增殖性狼疮性肾炎患者的疗效和安全性：利妥昔单抗狼疮性肾炎评估研究
Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9.
7
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.利妥昔单抗治疗中度至重度活动性系统性红斑狼疮的疗效和安全性：利妥昔单抗治疗系统性红斑狼疮的随机、双盲、II/III期试验
Arthritis Rheum. 2010 Jan;62(1):222-33. doi: 10.1002/art.27233.